Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey

European Journal of Haematology
Timothy DevosWim Pluymers

Abstract

The current survey aimed to gather predefined disease parameters and treatment strategies to characterize the polycythemia vera (PV) patient population in Belgium. Cross-sectional data from PV patients, seen at least once between May 2014 and May 2015 at 10 sites in Belgium, were collected in aggregated form and analyzed descriptively and quantitatively. Data from 343 PV patients were collected. Of these, 174 (50.7%) were male and 256 (74.6%) were ≥60 years of age. Ninety-two (26.8%) had a prior history of thrombotic events. Considerable proportions of patients had increased hematological parameters (hematocrit > 45% [31.2%], leukocytes > 10 × 109 /L [33.3%], and platelet > 400 × 109 /L [38.2%]). Most patients had non-palpable spleen (284, 87.7%) and no phlebotomies during the past 6 months (197, 57.4%). Low-dose aspirin was given as thrombosis prophylaxis in 249 (72.6%) patients, while 232 (67.6%) received hydroxyurea (HU) as cytoreductive treatment. Forty-one patients (12.0%) were reported as resistant and/or intolerant to HU. Seventeen patients (5.0%) received ruxolitinib in the context of clinical trials. This survey provides better insight into the characteristics of Belgian PV patients and currently used treatment strateg...Continue Reading

References

Nov 16, 2004·The American Journal of Medicine·Francesco PassamontiMario Lazzarino
May 26, 2007·Seminars in Thrombosis and Hemostasis·Ayalew Tefferi, Michelle Elliott
Mar 20, 2010·Internal and Emergency Medicine·Raffaele LandolfiLeonardo Di Gennaro
May 23, 2012·Blood·Francesco Passamonti
Jul 13, 2012·Blood Reviews·Tiziano BarbuiGuido Finazzi
Jun 19, 2013·Leukemia & Lymphoma·Jyotsna MehtaRuben Mesa
Jan 1, 2014·European Journal of Haematology·Odile MoulardRuben A Mesa
Oct 4, 2014·Blood·Alessandro M Vannucchi
Jan 23, 2015·American Journal of Hematology·Ayalew Tefferi, Tiziano Barbui
Jan 30, 2015·The New England Journal of Medicine·Alessandro M VannucchiSrdan Verstovsek
Apr 3, 2015·Annals of Hematology·Martin GriesshammerRuben Mesa
Oct 1, 2016·Haematologica·Alberto Alvarez-LarránUNKNOWN Grupo Español de Neoplasias Mieloproliferativas Filadelfia Negativas

❮ Previous
Next ❯

Citations

Jul 13, 2019·European Journal of Haematology·Claire van de Ree-PellikaanPeter E Westerweel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Alex E Denes
The New England Journal of Medicine
Fabienne DutrillauxPaule-Marie Carli
The New England Journal of Medicine
Carol Alliot
Expert Opinion on Pharmacotherapy
Marina KremyanskayaRonald Hoffman
© 2022 Meta ULC. All rights reserved